V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280004019 | 280002909 | 1.61 | 97 | Palliative (P) | 2016-03-05 | 2016-03-15 | EOX | N | N | 280026584 | EOX |
| 280004020 | 280002910 | 1.65 | 96 | Palliative (P) | 2016-06-26 | 2016-06-27 | Cisplatin + Gemcitabine (D 1 & 8) | 2 | N | 280026593 | CISPLATIN + GEMCITABINE |
| 280004021 | 280002911 | 0 | 105.3 | Palliative (P) | 2013-08-16 | 2013-08-20 | Trial Unspecified | N | N | 280026594 | TRIAL |
| 280004022 | 280002912 | 1.56 | null | Palliative (P) | 2013-06-09 | 2013-06-17 | CETUXIMAB | Y | N | 280026600 | CETUXIMAB |
| 280004023 | 280002913 | 1.75 | 81.6 | Not known (9) | 2016-06-08 | 2016-06-20 | CARBOPLATIN + RT | N | N | 280026601 | CARBOPLATIN + RT |
| 280004024 | 280002913 | 1.52 | 58 | Not known (9) | 2014-05-13 | 2014-05-14 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | 280026601 | CISPLATIN + GEMCITABINE |
| 280004025 | 280002914 | 1.73 | 94.8 | Palliative (P) | 2017-01-20 | 2017-02-03 | Cetuximab 7 day (Cycle 1) | N | N | 280026606 | CETUXIMAB |
| 280004026 | 280002914 | 1.78 | 113.9 | Not known (9) | 2014-04-17 | 2014-05-05 | Carboplatin AUC 2 - 5 | N | N | 280026606 | CARBOPLATIN |
| 280004027 | 280002915 | 1.54 | 45 | Palliative (P) | 2016-02-11 | 2016-03-10 | STS Rhabdomyosarcoma RMS 2005 IVAVV | N | N | 280026608 | NOT MATCHED |
| 280004028 | 280002916 | 1.77 | 60.4 | Palliative (P) | 2016-04-07 | 2016-04-25 | EOX | N | N | 280026610 | EOX |
| 280004029 | 280002916 | 1.8 | 78 | Palliative (P) | 2017-12-25 | 2018-01-11 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280026610 | CARBOPLATIN + PACLITAXEL |
| 280004030 | 280002916 | 1.68 | 61.2 | null | null | 2016-07-14 | Cetuximab 7 day (Cycle 1) | 2 | null | 280026610 | CETUXIMAB |
| 280004031 | 280002917 | 1.73 | null | null | null | 2016-01-17 | Carboplatin + Etoposide iv&po | null | null | 280026614 | CARBOPLATIN + ETOPOSIDE |
| 280004032 | 280002917 | 1.78 | 70.1 | Neo-adjuvant (N) | 2013-12-27 | 2013-12-27 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 280026614 | CISPLATIN + GEMCITABINE |
| 280004033 | 280002918 | 1.71 | 75 | Palliative (P) | 2016-10-27 | 2016-10-31 | Carboplatin + Paclitaxel (3 weekly) | N | N | 280026620 | CARBOPLATIN + PACLITAXEL |
| 280004034 | 280002919 | 1.71 | 60.6 | Palliative (P) | 2017-10-12 | 2017-10-12 | Carboplatin + Etoposide iv&po | Y | Y | 280026622 | CARBOPLATIN + ETOPOSIDE |
| 280004035 | 280002919 | 1.69 | 106.2 | Palliative (P) | 2013-05-29 | 2013-06-02 | Cetuximab 7 day (Cycle 1) | null | null | 280026622 | CETUXIMAB |
| 280004036 | 280002919 | 1.76 | 80.9 | Palliative (P) | 2015-06-01 | 2015-06-22 | EOX | N | N | 280026622 | EOX |
| 280004037 | 280010953 | 1.58 | 62.2 | Disease modification (D) | 2013-03-31 | 2013-04-17 | CARBOPLATIN + RT | N | N | 280026625 | CARBOPLATIN + RT |
| 280004038 | 280002920 | null | 66 | null | null | 2016-03-25 | Carboplatin AUC 6 - 10 | N | N | 280026626 | CARBOPLATIN |
| 280004039 | 280002920 | 1.7 | 91 | Palliative (P) | 2017-04-30 | 2017-04-30 | CARBOPLATIN + RT | null | N | 280026626 | CARBOPLATIN + RT |
| 280004040 | 280009794 | 1.78 | 77.9 | Palliative (P) | 2018-02-06 | 2018-02-06 | CARBOPLATIN + RT | N | N | 280026630 | CARBOPLATIN + RT |
| 280004041 | 280009794 | 1.5 | 103.9 | Palliative (P) | 2016-12-29 | 2016-12-30 | Carboplatin + Etoposide iv&po | 02 | N | 280026630 | CARBOPLATIN + ETOPOSIDE |
| 280004042 | 280009794 | 1.74 | 73.05 | null | 2014-11-14 | 2014-12-02 | CARBOPLATIN + RT | N | N | 280026630 | CARBOPLATIN + RT |
| 280004043 | 280009794 | null | null | Palliative (P) | 2017-10-22 | 2017-10-22 | EW EuroEwing 2012 Arm B IE | 2 | N | 280026630 | TRIAL |
| 280004044 | 280009794 | 1.7 | 88.3 | Palliative (P) | 2016-11-29 | 2016-12-21 | CARBOPLATIN + PACLITAXEL | null | null | 280026630 | CARBOPLATIN + PACLITAXEL |
| 280004045 | 280009794 | null | 63.4 | Palliative (P) | 2016-07-25 | 2016-08-05 | Carboplatin AUC 2 - 5 | null | null | 280026630 | CARBOPLATIN |
| 280004046 | 280002921 | null | 101.6 | Palliative (P) | 2015-04-09 | 2015-04-09 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | null | 280026642 | NOT MATCHED |
| 280004047 | 280007445 | 1.76 | 95 | Palliative (P) | 2016-11-28 | 2016-12-06 | Cetuximab 7 day (Cycle 1) | Y | N | 280026645 | CETUXIMAB |
| 280004048 | 280002922 | 1.77 | null | Palliative (P) | null | 2016-06-08 | CARBOPLATIN + ETOPOSIDE | 02 | null | 280026646 | CARBOPLATIN + ETOPOSIDE |
| 280004049 | 280002923 | 1.7 | 74.2 | Curative (C) | 2015-09-12 | 2015-09-13 | Trial Unspecified | 2 | N | 280026648 | TRIAL |
| 280004050 | 280002924 | 1.73 | 103.7 | Palliative (P) | 2014-06-05 | 2014-06-10 | CARBOPLATIN | Y | N | 280026649 | CARBOPLATIN |
| 280004051 | 280007446 | 0 | 99.5 | Palliative (P) | 2017-01-05 | 2017-01-14 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280026651 | NOT MATCHED |
| 280004052 | 280007446 | 1.7 | 83 | Palliative (P) | null | 2016-07-01 | Carboplatin AUC 6 - 10 | N | N | 280026651 | CARBOPLATIN |
| 280004053 | 280002925 | 1.5 | 67.6 | Palliative (P) | 2013-11-22 | 2013-11-29 | Carboplatin + Etoposide iv&po | N | N | 280026655 | CARBOPLATIN + ETOPOSIDE |
| 280004054 | 280002926 | 1.74 | 93.9 | Palliative (P) | 2016-04-20 | 2016-05-11 | Cetuximab 7 day (Cycle 1) | 2 | N | 280026656 | CETUXIMAB |
| 280004055 | 280002927 | 1.7 | 108.2 | Palliative (P) | 2016-06-20 | 2016-06-20 | Carboplatin + Etoposide iv&po | N | N | 280026657 | CARBOPLATIN + ETOPOSIDE |
| 280004056 | 280002927 | 1.73 | 76 | Palliative (P) | 2013-12-15 | 2013-12-15 | CETUXIMAB | N | N | 280026657 | CETUXIMAB |
| 280004057 | 280002927 | 1.51 | 53.35 | 4 | 2016-02-02 | 2016-03-01 | Cetuximab 7 day (Cycle 1) | Y | null | 280026657 | CETUXIMAB |
| 280004058 | 280002928 | 1.65 | 91.2 | Palliative (P) | null | 2018-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 280026660 | CARBOPLATIN + PACLITAXEL |
| 280004059 | 280002928 | 1.51 | 88.4 | Palliative (P) | 2016-10-23 | 2016-10-24 | CARBOPLATIN + RT | N | N | 280026660 | CARBOPLATIN + RT |
| 280004060 | 280002929 | 1.75 | 87.1 | Palliative (P) | 2013-08-22 | 2013-08-31 | Carboplatin + Etoposide IV 3 day | null | 2 | 280026662 | CARBOPLATIN + ETOPOSIDE |
| 280004061 | 280002930 | 1.65 | null | Palliative (P) | 2017-10-15 | 2017-10-15 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | N | 280026663 | NOT MATCHED |
| 280004062 | 280002930 | 1.58 | null | Palliative (P) | 2017-11-29 | 2017-12-04 | EOX | null | N | 280026663 | EOX |
| 280004063 | 280002931 | 1.78 | 76 | Palliative (P) | 2014-04-24 | 2014-05-06 | Carboplatin AUC 6 - 10 | 2 | N | 280026670 | CARBOPLATIN |
| 280004064 | 280002931 | 1.85 | null | null | 2014-03-06 | 2014-03-24 | Cetuximab 7 day (Cycle 1) | N | N | 280026670 | CETUXIMAB |
| 280004065 | 280002932 | null | 73.8 | Palliative (P) | 2017-10-20 | 2017-10-23 | STS Rhabdomyosarco RMS 2005 IVADoVV | 2 | N | 280026672 | NOT MATCHED |
| 280004066 | 280002933 | 1.67 | null | Not known (9) | 2016-02-23 | 2016-02-24 | EOX | N | N | 280026673 | EOX |
| 280004067 | 280002934 | 1.81 | 116 | Palliative (P) | 2013-02-06 | 2013-02-26 | EOX | 02 | N | 280026675 | EOX |
| 280004068 | 280002934 | 1.63 | 62.2 | null | 2013-12-20 | 2014-01-17 | CARBOPLATIN + RT | 02 | N | 280026675 | CARBOPLATIN + RT |